Listing 1 - 10 of 12 | << page >> |
Sort by
|
Choose an application
Choose an application
Pharmaceutical Preparations --- Pharmacology --- Nucleotides --- Pharmacology, Clinical --- Biological Science Disciplines --- Nucleotides, Cyclic. --- Cyclic Nucleotides --- cyclic --- cyclic. --- Cyclic. --- Cyclic Nucleotide --- Nucleotide, Cyclic --- Nucleotides, Cyclic
Choose an application
The stories behind drug discovery are fascinating, full of human and scientific interest. This is a book on the history of drug discovery that highlights the intellectual splendor of discoverers as well as the human frailty associated with them. History is replete with examples of breakthrough medicines that have saved millions of lives. Ether as an anesthetic by Morton; penicillin as an antibiotic by Fleming; and insulin as an anti-diabetic by Banting are just a few examples. The discoverers of these medicines are doubtlessly benefactors to mankind - for instance, without penicillin, 75% of us probably would not be alive because some of our parents or grandparents would have succumbed to infections. The text is supplemented by many anecdotes, pictures and postage stamps.
Drugs --- Nitrous oxide. --- Sildenafil. --- Viagra (Trademark) --- Cyclic nucleotide phosphodiesterases --- Laughing-gas --- Anesthetics --- Nitrogen oxides --- Medicaments --- Medications --- Medicine (Drugs) --- Medicines (Drugs) --- Pharmaceuticals --- Prescription drugs --- Bioactive compounds --- Medical supplies --- Pharmacopoeias --- Chemotherapy --- Materia medica --- Pharmacology --- Pharmacy --- Inhibitors
Choose an application
Calcium --- Glycerides --- Nucleotides, Cyclic --- Phosphoproteins --- Sugar Phosphates --- Secondary ion mass spectrometry --- Phosphoprotéines --- Spectrométrie de masse des ions secondaires --- periodicals --- Periodicals --- Périodiques --- Calcium. --- Nucleotides, Cyclic. --- Phosphoproteins. --- Cyclic Nucleotides --- Blood Coagulation Factor IV --- Coagulation Factor IV --- Factor IV --- Factor IV, Coagulation --- metabolism. --- Phosphoprotéines --- Spectrométrie de masse des ions secondaires --- Périodiques --- MDBIOCHE --- metabolism --- periodicals. --- Calcium-40 --- Calcium 40 --- Periodicals. --- Phosphoprotein --- Cyclic Nucleotide --- Nucleotide, Cyclic
Choose an application
With the advent of such oral drugs as Viagra®, Cialis®, and Levitra® for the treatment of erectile dysfunction (ED), the burden of first patient evaluation has fallen on the primary care provider. In Oral Pharmacotherapy for Male Sexual Dysfunction: A Guide to Clinical Management, highly experienced urologists and physician researchers review each aspect of male sexual dysfunction (interest, performance, and orgasm) and their implications for treatment. The authors address a wide variety of clinical issues, ranging from common medical risk factors for ED to the evaluation and management of men who have atypical presentations that require focused testing; from diabetic ED to the safety assessment of PDE inhibitors for cardiac patients; and from combination drug therapy for refractory patients to neuropharmacological therapies. Guidance is also provided for vacuum erection devices and surgical implants, the role of self-medication with dietary supplements, the management of post-prostatectomy ED, and the emerging pharmaceutical therapies for rapid ejaculation. On the pharmaceutical side, the authors summarize the pharmacology and development of PDE-type 5 inhibitors, review the preclinical data and 5 years of postmarketing data on Viagra®, examine the preclinical data on Levitra®, and discuss the design and conduct of US clinical trials of Cialis®. Authoritative and informative, Oral Pharmacotherapy for Male Sexual Dysfunction: A Guide to Clinical Management clarifies for urologists, family physicians, and internists each of the diagnostic approaches to male sexual dysfunction, as well as the pharmacological strategies available for its safe and effective management.
Impotence, Vasculogenic --- Phosphodiesterase Inhibitors --- Salvage Therapy --- Vasodilator Agents --- Impotence. --- Impotence --- Cyclic nucleotide phosphodiesterases --- Impuissance sexuelle --- drug therapy. --- therapeutic use. --- methods. --- Chemotherapy. --- Inhibitors --- Therapeutic use. --- Cyclic nucleotide phosphodiesterases -- Inhibitors -- Therapeutic use. --- Impotence -- Chemotherapy. --- Combined Modality Therapy --- Therapeutics --- Cardiovascular Agents --- Investigative Techniques --- Enzyme Inhibitors --- Erectile Dysfunction --- Sexual Dysfunction, Physiological --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Molecular Mechanisms of Pharmacological Action --- Therapeutic Uses --- Pharmacologic Actions --- Genital Diseases, Male --- Chemical Actions and Uses --- Male Urogenital Diseases --- Chemicals and Drugs --- Diseases --- Methods --- Drug Therapy --- Medicine --- Health & Biological Sciences --- Urology & Nephrology --- Chemotherapy --- Therapeutic use --- E.D. (Erectile dysfunction) --- ED (Erectile dysfunction) --- Erectile dysfunction --- Impotency --- Medicine. --- Urology. --- Medicine & Public Health. --- Genitourinary organs --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Phosphodiesterases --- Sexual disorders
Choose an application
Genetics --- Human biochemistry --- Animal biochemistry --- Enzymology --- Molecular biology --- Calcium --- Nucleotides, Cyclic --- Phosphoproteins --- Cyclic nucleotides --- Phosphorylation --- Proteins --- Nucléotides cycliques --- Phosphoprotéines --- Protéines --- periodicals --- Physiological effect --- Periodicals --- Metabolism --- Effets physiologiques --- Périodiques --- Métabolisme --- Calcium. --- Nucleotides, Cyclic. --- Phosphoproteins. --- Protein Kinases --- #TS:KOMA --- Protein Kinase --- Kinase, Protein --- Kinases, Protein --- Cell Cycle Proteins --- Cyclic Nucleotides --- Blood Coagulation Factor IV --- Coagulation Factor IV --- Factor IV --- Factor IV, Coagulation --- Nucléotides cycliques --- Phosphoprotéines --- Protéines --- Périodiques --- Métabolisme --- MDBIOCHE --- periodicals. --- Calcium-40 --- Calcium 40 --- Periodicals. --- Phosphoprotein --- Cyclic Nucleotide --- Nucleotide, Cyclic
Choose an application
Cyclic nucleotides --- Physiology, Pathological --- Nucleotides, Cyclic --- Congresses --- Nucleotides, Cyclic. --- 577.113.3 <063> --- -Physiology, Pathological --- -Clinical physiology --- Pathological physiology --- Pathophysiology --- Physiopathology --- Pathology --- Physiology --- Nucleotides --- Cyclic Nucleotides --- Nucleosides, nucleotides and nitrogen bases.Nucleotide composition of nucleic acids.--Congressen --- Conferences - Meetings --- -Nucleosides, nucleotides and nitrogen bases.Nucleotide composition of nucleic acids.--Congressen --- 577.113.3 <063> Nucleosides, nucleotides and nitrogen bases.Nucleotide composition of nucleic acids.--Congressen --- -Cyclic Nucleotides --- Clinical physiology --- Cyclic Nucleotide --- Nucleotide, Cyclic --- Cyclic nucleotides - Congresses --- Physiology, Pathological - Congresses --- Nucleotides, Cyclic - congresses
Choose an application
A signature feature of living organisms is their ability to carry out purposeful actions by taking stock of the world around them. To that end, cells have an arsenal of signaling molecules linked together in signaling pathways, which switch between inactive and active conformations. The Molecular Switch articulates a biophysical perspective on signaling, showing how allostery—a powerful explanation of how molecules function across all biological domains—can be reformulated using equilibrium statistical mechanics, applied to diverse biological systems exhibiting switching behaviors, and successfully unify seemingly unrelated phenomena.Rob Phillips weaves together allostery and statistical mechanics via a series of biological vignettes, each of which showcases an important biological question and accompanying physical analysis. Beginning with the study of ligand-gated ion channels and their role in problems ranging from muscle action to vision, Phillips then undertakes increasingly sophisticated case studies, from bacterial chemotaxis and quorum sensing to hemoglobin and its role in mammalian physiology. He looks at G-protein coupled receptors as well as the role of allosteric molecules in gene regulation. Phillips concludes by surveying problems in biological fidelity and offering a speculative chapter on the relationship between allostery and biological Maxwell demons.Appropriate for graduate students and researchers in biophysics, physics, engineering, biology, and neuroscience, The Molecular Switch presents a unified, quantitative model for describing biological signaling phenomena.
Cellular signal transduction. --- Cellular control mechanisms. --- Cell regulation --- Biological control systems --- Cell metabolism --- Cellular information transduction --- Information transduction, Cellular --- Signal transduction, Cellular --- Bioenergetics --- Cellular control mechanisms --- Information theory in biology --- Alexander Gann. --- Bohr effect. --- Bruce Mayer. --- Cell Signaling. --- Genes and Signals. --- MWC enzymes. --- Mark Ptashne. --- Michaelis-Menten Enzymes. --- Tony Pawson. --- Wendell Lim. --- allosterome. --- bacterial aerotaxis. --- cyclic nucleotide gated channels. --- enzyme phenomenology. --- gene expression. --- genome packing. --- glycolosis. --- ligand-receptor binding. --- logic gates. --- membrane receptors. --- nucleosomes. --- phoshofructokinase. --- signal transduction.
Choose an application
Cyclic nucleotide phosphodiesterases (PDEs) are promising targets for pharmacological intervention. Multiple PDE genes, isoform diversity, selective expression and compartmentation of the isoforms, and an array of conformations of PDE proteins are properties that challenge development of drugs that selectively target this class of enzymes. Novel characteristics of PDEs are viewed as unique opportunities to increase specificity and selectivity when designing novel compounds for certain therapeutic indications. This chapter provides a summary of the major concepts related to the design and use of PDE inhibitors.
Chemical structure --- cytologie --- Clinical chemistry --- biochemie --- Histology. Cytology --- moleculaire structuur --- General biochemistry --- biosynthese --- genetische manipulatie --- massaspectrometrie --- toxicologie --- polypeptiden --- aminozuren --- eiwitten --- Pharmacology. Therapy --- medische chemie --- Organic spectroscopy --- Cyclic nucleotide phosphodiesterases. --- Drug targeting. --- Toxicology. --- Biochemistry. --- Enzymes. --- Post-translational modification . --- Cell physiology. --- Pharmacology/Toxicology. --- Medicinal Chemistry. --- Protein Structure. --- Enzymology. --- Posttranslational Modification. --- Cell Physiology. --- Cell function --- Cytology --- Physiology --- Co-translational modification --- Cotranslational modification --- Modification, Post-translational --- Post-translation protein modification --- Post-translational protein modification --- Posttranslation protein modification --- Posttranslational modification --- Posttranslational protein modification --- Genetic translation --- Proteins --- Biocatalysts --- Ferments --- Soluble ferments --- Catalysts --- Enzymology --- Biological chemistry --- Chemical composition of organisms --- Organisms --- Physiological chemistry --- Biology --- Chemistry --- Medical sciences --- Chemicals --- Medicine --- Pharmacology --- Poisoning --- Poisons --- Synthesis --- Composition --- Toxicology --- Pharmacology. --- Medicinal chemistry. --- Proteins . --- Posttranslational modification. --- Biochemistry --- Enzymes --- Proteids --- Biomolecules --- Polypeptides --- Proteomics --- Chemistry, Medical and pharmaceutical --- Chemistry, Pharmaceutical --- Drug chemistry --- Drugs --- Medical chemistry --- Medicinal chemistry --- Pharmacochemistry --- Drug effects --- Medical pharmacology --- Chemotherapy --- Pharmacy --- Physiological effect --- Phosphodiesterases. --- Analysis.
Choose an application
Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are in vivo molecular imaging methods which are widely used in nuclear medicine for diagnosis and treatment follow-up of many major diseases. These methods use target-specific molecules as probes, which are labeled with radionuclides of short half-lives that are synthesized prior to the imaging studies. These probes are called radiopharmaceuticals. The use of PET and SPECT for brain imaging is of special significance since the brain controls all the body’s functions by processing information from the whole body and the outside world. It is the source of thoughts, intelligence, memory, speech, creativity, emotion, sensory functions, motion control, and other important body functions. Protected by the skull and the blood–brain barrier, the brain is somehow a privileged organ with regard to nutrient supply, immune response, and accessibility for diagnostic and therapeutic measures. Invasive procedures are rather limited for the latter purposes. Therefore, noninvasive imaging with PET and SPECT has gained high importance for a great variety of brain diseases, including neurodegenerative diseases, motor dysfunctions, stroke, epilepsy, psychiatric diseases, and brain tumors. This Special Issue focuses on radiolabeled molecules that are used for these purposes, with special emphasis on neurodegenerative diseases and brain tumors.
Research & information: general --- Biology, life sciences --- SV2A --- SV2B --- SV2C --- microPET --- [18F]UCB-H --- epilepsy --- PBIF --- distribution volume --- blocking assay --- preclinical imaging --- Alzheimer’s disease (AD) --- network measure --- graph theory --- brain network --- positron emission tomography (PET) --- persistent homology --- Phosphodiesterase 2A (PDE2A) --- Positron Emission Tomography (PET) --- Benzoimidazotriazine (BIT) --- fluorinated --- Mouse Liver Microsomes (MLM) --- cyclic nucleotide phosphodiesterase --- PDE2A radioligand --- nitro-precursor --- fluorine-18 --- in vitro autoradiography --- PET imaging --- opioid receptors --- positron emission tomography --- radiotracers --- μOR-, δOR-, κOR- and ORL1-ligands --- movement disorders --- pain --- drug dependence --- GBM --- biomarkers --- Sigma 1 --- Sigma 2 --- PD-L1 --- PARP --- IDH --- Alzheimer’s disease --- Parkinson’s disease --- β-amyloid plaques --- neurofibrillary tangles --- α-synucleinopathy --- diagnostic imaging probes --- orexin receptors --- PET --- radiotracer --- imaging --- alpha 7 --- nicotinic acetylcholine receptors --- nAChR --- autoradiography --- amino acid --- FET --- FACBC --- FDOPA --- immunoPET --- molecular imaging --- glioma --- brain metastases --- adenosine A2A receptor --- rotenone-based mouse model --- [18F]FESCH --- two-step one-pot radiosynthesis
Listing 1 - 10 of 12 | << page >> |
Sort by
|